Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Dtsch Med Wochenschr ; 134(30): 1517-9, 2009 Jul.
Artigo em Alemão | MEDLINE | ID: mdl-19603366

RESUMO

HISTORY AND ADMISSION FINDINGS: A 50-year-old woman presented with progressive dysphagia and chest pain. Clinical and laboratory findings revealed a moderate epigastric pain and moderately elevated D-dimers. She had previously been diagnosed with esophagitis. Current oral medication included risedonate and clindamycin. INVESTIGATIONS: The electrocardiogram was appropriate for age, with a SIQIII-sign and sinus tachycardia. Echocardiography, abdominal sonography and chest X-ray were unremarkable. Gastroscopy demonstrated severe inflammatory lesions in the middle part of the esophagus. The biopsies revealed crystalline material microscopically. TREATMENT AND COURSE: The findings supported the diagnosis of an acute exacerbation of a chronic risedronat-induced esophagitis caused by clindamycin. After discontinuing the oral medication and giving intermittent parenteral nutrition the lesions healed completely. CONCLUSION: Drug-induced esophagitis is often not recognized. Because of the high number of patients on bisphosphonate medication, often in combination with other potentially ulcerogenic drugs, the differential diagnosis should include drug-induced esophagitis.


Assuntos
Antibacterianos/efeitos adversos , Conservadores da Densidade Óssea/efeitos adversos , Clindamicina/efeitos adversos , Esofagite/diagnóstico , Ácido Etidrônico/análogos & derivados , Doença Aguda , Antibacterianos/uso terapêutico , Conservadores da Densidade Óssea/uso terapêutico , Clindamicina/uso terapêutico , Diagnóstico Diferencial , Quimioterapia Combinada , Esofagite/induzido quimicamente , Esofagite/terapia , Ácido Etidrônico/efeitos adversos , Ácido Etidrônico/uso terapêutico , Feminino , Refluxo Gastroesofágico/diagnóstico , Refluxo Gastroesofágico/tratamento farmacológico , Humanos , Pessoa de Meia-Idade , Osteoporose Pós-Menopausa/tratamento farmacológico , Nutrição Parenteral , Ácido Risedrônico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...